Hoth Therapeutics, Inc. HOTH
Set alert
0.80 USD 0.00 0.00%
As of Aug 5, 3:59 PM ET
0.7911 Day range 0.835
0.58 52-week range 1.73
- YTD
- -19.06%
- 1 year
- -43.57%
- Open
- 0.82
- Prev close
- 0.8013
- Mkt cap
- 5.64M
- Vol
- 40.06K
- Avg vol
- 968.44K
- EPS
- -1.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7911
- High
- 0.835
- Forward P/E
- -1.15
- Beta
- 0.00
- Short ratio
- 0.25
- Inst. own
- 5.31%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 0.85156
- 200-d avg
- 0.978545
- 1y target
- 4.50
Financial health
Altman Z-Score
-10.68 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.1×
FY 2017 5y median -0.8× FY 2025
P/S 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 2.2×
FY 2017 5y median 1.5× FY 2025
P/FCF -1.4×
FY 2017 5y median -1.0× FY 2025
EV/EBITDA -0.6×
FY 2017 5y median -40.2× FY 2025
EV/Sales 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -71.7%
FY 2017 5y median -100.3% FY 2025
Profitability
Gross Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -202.7%
FY 2017 5y median -144.8% FY 2025
ROIC -180.5%
FY 2017 5y median -139.4% FY 2025
ROA -164.0%
FY 2017 5y median -130.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -35.2%
FY 2017 FY 2025
EPS (diluted) 29.7%
FY 2017 FY 2025
Free Cash Flow -40.5%
FY 2017 FY 2025
Financial Health
Current Ratio 4.7×
FY 2017 5y median 9.2× FY 2025
Quick Ratio 4.7×
FY 2017 5y median 9.2× FY 2025
Debt / Equity 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2017 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31